Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks
Completed
- Conditions
- Abdominal Aortic Aneurysm
- Registration Number
- NCT04409717
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
- All patients treated for type II endoleaks by endovascular therapy
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence rate of type II endoleaks treated with endovascular intervention 12 years
- Secondary Outcome Measures
Name Time Method Type of type II endoleaks treatment 12 years
Trial Locations
- Locations (1)
Cardiovascular and thoracic surgery unit, CHU Dijon
🇫🇷Dijon Cedex, France
Cardiovascular and thoracic surgery unit, CHU Dijon🇫🇷Dijon Cedex, France